Sanofi: EU grants marketing authorisation for Covid vaccine

(CercleFinance.com) - The Commission has granted a marketing authorisation as a booster dose for VidPrevtyn Beta, the protein-based COVID-19 vaccine developed by Sanofi and GSK, which becomes the seventh COVID-19 vaccine to be authorised in the EU.


This authorisation covers the use of the vaccine as a booster in adults after a primary vaccination with another COVID-19 vaccine.

The authorisation follows a positive scientific recommendation from the European Medicines Agency (EMA) based on a thorough evaluation of the safety, efficacy and quality of the vaccine.

Sanofi also announces that the CHMP of the European Medicines Agency has given a positive opinion for the approval of its Dupixent in the European Union for the treatment of moderate-to-severe nodular prurigo in adults as a candidate for systemic treatment.

However, the news is being completely ignored by investors, with Sanofi shares currently down 3%.


Copyright (c) 2022 CercleFinance.com. All rights reserved.